Status: current, Defined. Date: 30-Nov 2020. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4474351000168110 | Ondansetron ODT (APX) (ondansetron 4 mg) orally disintegrating tablet (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4474361000168112 | Ondansetron ODT (APX) 4 mg orally disintegrating tablet | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Ondansetron ODT (APX) 4 mg orally disintegrating tablet | Is a | Ondansetron ODT (APX) | true | Inferred relationship | Some | ||
| Ondansetron ODT (APX) 4 mg orally disintegrating tablet | Is a | trade product unit of use | true | Inferred relationship | Some | ||
| Ondansetron ODT (APX) 4 mg orally disintegrating tablet | Is a | ondansetron 4 mg orally disintegrating tablet | true | Inferred relationship | Some | ||
| Ondansetron ODT (APX) 4 mg orally disintegrating tablet | has manufactured dose form | orally disintegrating tablet | true | Inferred relationship | Some | ||
| Ondansetron ODT (APX) 4 mg orally disintegrating tablet | has intended active ingredient | ondansetron | true | Inferred relationship | Some | 794867950 | |
| Ondansetron ODT (APX) 4 mg orally disintegrating tablet | has Australian BoSS | ondansetron | true | Inferred relationship | Some | 794867950 | |
| Ondansetron ODT (APX) 4 mg orally disintegrating tablet | has unit of use | tablet | true | Inferred relationship | Some | 1944359838 |
Reference Sets
Trade product unit of use reference set
FHIR